10 Best High Tech Stocks To Buy Right Now

Short-sellers tend to cash in their chips when their target stocks plunge downward. Why risk large losses when you have a solid profit on the table, right in front of you? But the most heavily shorted stocks on the Dow Jones Industrial Average (DJINDICES: ^DJI  ) today also happen to be some of its worst recent performers. What gives?

The single most shorted Dow stock right now is aluminum producer Alcoa (NYSE: AA  ) , according to the latest short-sales report. 8.9% of its shares have been borrowed and shorted, a 7.5% increase in two weeks.

The second and third names on this unfortunate list are Caterpillar (NYSE: CAT  ) and Intel (NASDAQ: INTC  ) , with just over and under 4.7% of their float sold short, respectively.

All three of these stocks have lagged their Dow peers significantly over the last year:

Best Communications Equipment Stocks To Own For 2015: Callaway Golf Co (ELY)

Callaway Golf Company, incorporated on May 7, 1999, together with its subsidiaries, designs, manufactures and sells golf clubs (drivers, fairway woods, hybrids, irons, wedges and putters) and golf balls, and also sells golf accessories (such as golf bags, golf gloves, headwear, towels, umbrellas and travel gear) under the Callaway Golf and Odyssey brand names. The Company sells pre-owned golf products through its Website, www.callawaygolfpreowned.com. In addition, it sells Callaway Golf and Odyssey products direct to consumers online through its Websites shop.callawaygolf.com and www.odysseygolf.com. The Company also licenses its trademarks and service marks in exchange for a royalty fee to third parties for use on golf related accessories, including apparel, footwear, eyewear, rangefinders and practice aids. Its products are sold in the United States and in approximately 100 countries around the world.

The Company designs, manufactures and sells golf clubs and golf balls, and designs and sells golf accessories. The Company�� products are designed for golfers of all skill levels, both amateur and professional. The Company�� principal products include Drivers, Fairway Woods and Hybrids; Irons; Putters; Golf Balls, and Accessories, Softgoods and Other. Drivers, Fairway Woods and Hybrids product category includes sales of the Company�� drivers, fairway woods and hybrid products, which are sold under the Callaway Golf brand. Irons include sales of the Company�� irons and wedges, which are sold under the Callaway Golf brand. Putters include sales of the Company�� putters, which are sold under the Odyssey brand. Golf Balls includes sales of the Company�� golf balls, which are sold under the Callaway Golf and Strata brands. Accessories, Softgoods and Other includes sales of golf bags, golf gloves, golf footwear, rangefinders, golf apparel, packaged club sets, headwear, towels, umbrellas, eyewear and other accessories, as well as sales of pre-owned products through www.callawaygolfpre! owned.com. Additionally, this product category includes royalties from licensing of the Company�� trademarks and service marks on products such as golf apparel, golf footwear, rangefinders and practice aids.

The Company competes with TaylorMade, Ping, Acushnet, Puma, SRI Sports Limited, Mizuno, Bridgestone, and Nike.

Advisors' Opinion:

• [By Charley Blaine]

  Callaway Golf (NYSE: ELY) was also up, gaining 19.83 percent to $8.70 after the company reported a narrower third-quarter loss and lifted its 2013 forecast. DA Davidson upgraded the stock from Neutral to Buy and lifted its price target from $7.50 to $11.

• [By Greg Pugh] Callaway Golf Company (NYSE: ELY) has forged a reputation as a leader in golf equipment innovation. However, the company started sliding in 2008 due to recession, while the brand image fell as well. US industry golf sales hit a floor and flattened just above $1.8 billion between 2009 and 2011, but have started to rebound in the last two years.
• [By Lauren Pollock]

  Callaway Golf Co.'s(ELY) third-quarter loss narrowed significantly as the golf equipment maker reported a jump in sales and sharp increase in gross margins. Results for the period easily topped Wall Street’s expectations, sending shares up.

10 Best High Tech Stocks To Buy Right Now: Veolia Environnement(VE)

Veolia Environnement S.A., together with its subsidiaries, provides environmental management services to individuals, public authorities, and industrial and commercial services customers worldwide. It operates in four segments: Water, Environmental Services, Energy Services, and Transportation. The Water segment offers water and wastewater services, including the management and operation of large-scale and customized drinking water plants, wastewater decontamination and recycling plants, drinking water distribution networks, and wastewater collection networks; and provision of call centers and billing services. The Environmental Services segment provides waste management and logistical services, which include waste collection, waste processing, cleaning of public spaces, maintenance of production equipment, treatment of polluted soil, and management of waste discharge at industrial sites. The Energy Services segment offers a range of energy management services comprising o peration of heating and cooling networks, decentralized energy production, thermal and multi-technical services, industrial utilities, installation and maintenance of production equipment, integrated facilities management, and electrical services on public streets and roads; and provides heating systems maintenance services, plumbing and renewable energy services, and meter-reading services. The Transportation segment operates various bus networks, suburban trains, tramways, metros, and ferries, as well as offers customized transportation-on-demand services. This segment also provides intercity and regional passenger transportation, infrastructure management and airport services, and transportation management services. The company was formerly known as Vivendi Environnement and changed its name to Veolia Environnement S.A. in April 2003. Veolia Environnement S.A. was founded in 1853 and is headquartered in Paris, France.

Advisors' Opinion:

• [By Benjamin Shepherd]

  The first is to focus on infrastructure companies that lay the groundwork for easier water access, such as France-based Veolia Environment (NYSE: VE).

10 Best High Tech Stocks To Buy Right Now: bluebird bio Inc (BLUE)

bluebird bio, Inc., incorporated on April 16, 1992, is a clinical-stage biotechnology company, the Company is focused on transforming the lives of patients with severe genetic and orphan diseases using gene therapy. Gene therapy seeks to introduce a functional copy of the defective gene into a patient�� own cells, a process called gene transfer. Through gene transfer, a functional copy of the mutated gene is delivered to the patient�� cells, thereby correcting the underlying genetic defect that causes aberrant gene expression. As of December 31, 2012, the Company is conducting a Phase I/II clinical study in France evaluating an earlier generation of its LentiGlobin vector for the treatment of �-thalassemia major and SCD. Initial proof-of-concept data from this study were published in Nature. During the year ended December 31, 2013, the Company plans to initiate an extension of this study under a revised protocol for LentiGlobin, which the Company refers to as the HGB-205 Study. The Company also plans o initiate a second Phase I/II clinical program in the United States for LentiGlobin, which the Company refers to as the HGB-204 Study, for �-thalassemia major. In March 2013, the Company entered into a strategic collaboration with Celgene Corporation, or Celgene, to discover, develop and commercialize, disease-altering gene therapies in oncology.

Its gene therapy platform is based on viral vectors that utilize a modified, non-replicating version of the Human Immunodeficiency Virus Type 1 (HIV-1) virus, that has been stripped of all of the components required for it to self-replicate and infect additional cells. The HIV-1 virus is part of the lentivirus family of viruses, as a result of which the Company refer to its vectors as lentiviral vectors. Its lentiviral vectors are used to introduce a functional copy of a gene to the patient�� own isolated blood stem cells, called hematopoietic stem cells (HSCs), which reside in a patient�� bone marrow and are capable of differentiating int! o a wide range of cell types. HSCs are dividing cells, thus its approach allows for sustained expression of the modified gene as the Company is able to take advantage of a lifetime of replication of the gene-modified HSCs. Additionally, the Company has developed a cell-based vector manufacturing process that is both reproducible and scalable.

Adrenoleukodystrophy

Adrenoleukodystrophy is a rare X-linked, inherited, neurological disorder that is often fatal. ALD is caused by mutations in the ABCD1 gene which encodes for a protein called the ALD protein (ALDP), which plays a critical role in the breakdown and metabolism of long-chain fatty acids (VLCFA). Without functional ALDP, VLCFA accumulate in cells including neural cells in which they cause damage to the myelin sheath, a protective and insulating membrane that surrounds nerve cells in the brain. This damage can result in decreased motor coordination and function, visual and hearing disturbances, the loss of cognitive function, dementia, seizures, adrenal dysfunction and other complications, including death. ALD is divided into various sub-segments with three main phenotypes that impact brain function: CCALD (Childhood cerebral adrenoleukodystrophy, AMN (Adrenomyeloneuropathy) and ACALD (Adult Cerebral ALD).

�-thalassemia

�-thalassemia is a rare hereditary blood disorder caused by a genetic abnormality of the �-globin gene resulting in defective red blood cells (RBCs). Genetic mutations cause the absence or reduced production of the beta chains of hemoglobin, or �-globin, thereby preventing the proper formation of hemoglobin A, which normally accounts for greater than 95% of the hemoglobin in the blood of adults. Hemoglobin is an iron-containing protein in the blood that carries oxygen from the respiratory organs to the rest of the body. Hemoglobin A consists of four chains-two chains each of a-globin and �-globin. Normally existing at an approximate 1:1 ratio, genetic mutations that impair t! he produc! tion of �-globin can lead to a relative excess of a-globin, premature death of red blood cells. The clinical implications of the a-globin/�-globin imbalance are two-fold: first, patients lack sufficient RBCs and hemoglobin to effectively transport oxygen throughout the body and can become severely anemic; and second, the shortened life span and ineffective production of RBCs can lead to other complications such as splenomegaly, marrow expansion, bone deformities, and iron overload in organs.

Sickle cell disease

Sickle cell disease (SCD) is a hereditary blood disorder resulting from a mutation in the �-globin gene that causes polymerization of hemoglobin proteins and abnormal red blood cell function. The disease is characterized by anemia, vaso-occlusive pain crisis (a common complication of SCD in which there is severe pain due to obstructed blood flow in the bones, joints, lungs, liver, spleen, kidney, eye, or central nervous system), infections, stroke, overall poor life and early death in a subset of patients. Under low-oxygen conditions, which are exacerbated by the red blood cell abnormalities, the mutant hemoglobin aggregates causing the RBCs to take on a sickle shape (sickle cells), which causes them to aggregate and obstruct small blood vessels, thereby restricting blood flow to organs resulting in pain, cell death and organ damage. If oxygen levels are restored, the hemoglobin can disaggregate and the RBCs return to their normal shape, but over time, the sickling damages the cell membrane and the cells fail to return to the normal shape even in high-oxygen conditions.

Advisors' Opinion:

• [By David Williamson]

  In this video, health-care analyst David Williamson takes a look at the tremendous success of the�Bluebird Bio (NASDAQ: BLUE  ) �IPO. The company increased the size of its initial public offering, and priced shares at $17 -- above the top end of its range -- but that still couldn't contain investor appetite for this stock. Shares shot up 50% on the opening day of trading, and have remained there.

• [By Garrett Cook]

  Bluebird Bio (NASDAQ: BLUE) shares shot up 33.61 percent to $34.86 following the presentation of positive data on LentiGlobin BB305 at the European Hematology Association (EHA).

10 Best High Tech Stocks To Buy Right Now: NRG Yield Inc (NYLD)

NRG Yield, Inc., incorporated on December 20, 2012, serves as the primary vehicle, through which NRG Energy, Inc. will own, operate and acquire contracted renewable and conventional generation and thermal infrastructure assets. The Company owns a diversified portfolio of contracted renewable and conventional generation and thermal infrastructure assets in the United States. The Company�� contracted generation portfolio includes three natural gas or dual-fired facilities, eight utility-scale solar and wind generation facilities and two portfolios of distributed solar facilities that collectively represent 1,324 net megawatt. The Company also own thermal infrastructure assets with an aggregate steam and chilled water capacity of 1,098 net megawatt and electric generation capacity of 123 net megawatt. In December 2013, it acquired the assets of privately held Energy Systems Company.

The Company�� thermal infrastructure assets provide steam, hot water and/or chilled water, and in some instances electricity, to commercial businesses, universities, hospitals and governmental units in ten locations, principally through long-term contracts or pursuant to rates regulated by state utility commissions. The Company�� conventional operations consist of 910 net megawatt of natural gas and dual-fired generation assets, Marsh Landing and GenConn, located in the West and Northeast regions of the United States, respectively. The Company�� seven utility-scale solar generation assets generate electricity through the use of photovoltaic panels, with each facility equal to or exceeding 20 megawatt and collectively totaling 303 net megawatt of capacity. These facilities are located in Arizona, California and New Mexico, all states with attractive solar resources. The Company�� distributed solar generation facilities, which it generally define as facilities of less than 20 megawatt in operating capacity, each generate electricity through the use of photovoltaic panels.

The Company�� wind! operations are consists of the 101 megawatt South Trent wind farm located near Sweetwater, Texas. It consists of 44 Siemens 2.3 megawatt wind turbines capable, at rated capacity, of powering approximately 80,000 homes. The Company�� thermal operations are consists of district energy systems and combined heat and power plants (Energy Centers) that utilize an energy-efficient, environmentally sound method of heating and cooling buildings. These Energy Centers produce steam, hot water and/or chilled water and in some instances, electricity at a central plant.

Advisors' Opinion:

• [By Richard Stavros]

  For example, NRG Energy recently created a yield company spinoff, known as NRG Yield Inc (NYSE: NYLD). NRG Yield holds the parent company�� contracted assets and trades at a much higher multiple than NRG Energy.

• [By Marc Bastow]

  Thermal energy asset provider NRG Yield (NYLD) raised its quarterly dividend 10% to 33 cents per share, payable on Mar. 17 to shareholders of record as of Mar. 3.
  NYLD Dividend Yield: 3.32%

• [By Joshua Bondy]

  The Ivanpah project
  Recently the Ivanpah 392 megawatt (MW) CSP plant was competed in the Californian desert.�NRG Yield (NYSE: NYLD  ) and its parent company�NRG Energy (NYSE: NRG  ) �worked to bring the plant to fruition. The facility will help California reach its goal of 33% renewable energy production by 2020. Southern California Edison and Pacific Gas & Electric have already signed long-term agreements to buy power from the facility.�

• [By David Dittman]

  Question: Any comments on NRG Yield Inc (NYSE: NYLD), the IPO of NRG Energy from this year? Its looks set for strong dividend growth in the next couple years.

10 Best High Tech Stocks To Buy Right Now: Alnylam Pharmaceuticals Inc.(ALNY)

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel therapeutics based on RNA interference (RNAi). Its core product programs under clinical or pre-clinical development include ALN-TTR, a Phase I clinical trial program for the treatment of transthyretin-mediated amyloidosis; ALN-APC, a Phase I clinical trial program for the treatment of hemophilia; ALN-PCS for the treatment of severe hypercholesterolemia; ALN-HPN, a pre-clinical development for the treatment of refractory anemia; and ALN-TMP, a pre-clinical development for the treatment of hemoglobinopathies, including beta-thalassemia and sickle cell anemia. The company?s partner-based programs comprise ALN-RSV01, a Phase II clinical trial program for the treatment of respiratory syncytial virus infection; ALN-VSP, a Phase I clinical trial completed program for the treatment of liver cancers; and ALN-HTT, a pre-clinical development for the treatment of Huntington?s disease. It has strategic alliances with Novartis Pharma AG; F. Hoffmann-La Roche Ltd; Takeda Pharmaceutical Company Limited; Isis Pharmaceuticals, Inc.; Medtronic Inc.; Kyowa Hakko Kirin Co., Ltd.; and Cubist Pharmaceuticals, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.

Advisors' Opinion:

• [By Sean Williams]

  What: Shares of Alnylam Pharmaceuticals (NASDAQ: ALNY  ) , a biopharmaceutical company developing treatments based on RNA interference, vaulted 19% higher after the company announced positive top-line data for ALN-TTRsc.

• [By Jake L'Ecuyer]

  Equities Trading UP
  Shares of Alnylam Pharmaceuticals (NASDAQ: ALNY) got a boost, shooting up 53.25 percent to $101.47 after the company reported that it has acquired investigational RNAi Therapeutic assets from Merck (NYSE: MRK). Genzyme and Alnylam expanded their collaboration on rare genetic diseases.

• [By Keith Speights]

  Early validation
  Alnylam Pharmaceuticals (NASDAQ: ALNY  ) was another big winner this week, with shares jumping 32%. Good news from an early-stage study powered the stock's climb.

• [By Jake L'Ecuyer]

  Equities Trading UP
  Shares of Alnylam Pharmaceuticals (NASDAQ: ALNY) got a boost, shooting up early in the day, but settling on a gain of 40.40 percent to $92.96 after the company reported that it has acquired investigational RNAi Therapeutic assets from Merck (NYSE: MRK). Genzyme and Alnylam expanded their collaboration on rare genetic diseases.

10 Best High Tech Stocks To Buy Right Now: ()

DGS Minerals Inc., an exploration stage company, engages in the acquisition, exploration, and development of mineral properties in Canada. It primarily explores for gold. It holds an option to acquire a 100% interest in the Gordon Creek property, an epithermal precious metals project consisting of 4 mineral claims with an area of 2,066.08 hectares and is located northeast of Merritt, British Columbia. The company was formerly known as Challenger Development Corp. and changed its name to DGS Minerals Inc in April 2013. DGS Minerals Inc. was incorporated in 1990 and is based in Vancouver, Canada.

Advisors' Opinion:

• [By Gordon Pape]

  Rating: 0.0/5 (0 votes)

  Subscribe via Email Subscribe RSS Comments Please leave your comment:
  More GuruFocus Links Latest Guru Picks Value Strategies Warren Buffett Portfolio Ben Graham Net-Net Real Time Picks Buffett-Munger Screener Aggregated Portfolio Undervalued Predictable ETFs, Options Low P/S Companies Insider Trends 10-Year Financials 52-Week Lows Interactive Charts Model Portfolios DCF Calculator RSS Feed Monthly Newsletters The All-In-One Screener Portfolio Tracking Tool MORE GURUFOCUS LINKS Latest Guru Picks Value Strategies Warren Buffett Portfolio Ben Graham Net-Net Real Time Picks Buffett-Munger Screener Aggregated Portfolio Undervalued Predictable ETFs, Options Low P/S Companies Insider Trends 10-Year Financials 52-Week Lows Interactive Charts Model Portfolios DCF Calculator RSS Feed Monthly Newsletters The All-In-One Screener Portfolio Tracking Tool VET STOCK PRICE CHART 70.18 (1y: +39%) $(function(){var seriesOptions=[],yAxisOptions=[],name='VET',display='';Highcharts.setOptions({global:{useUTC:true}});var d=new Date();$current_day=d.getDay();if($current_day==5||$current_day==0||$current_day==6){day=4;}else{day=7;} seriesOptions[0]={id:name,animation:false,color:'#4572A7',lineWidth:1,name:name.toUpperCase()+' stock price',threshold:null,data:[[1371531600000,50.43],[1371618000000,51.16],[1371704400000,49.08],[1371790800000,48.476],[1372050000000,47.73],[1372136400000,48.17],[1372222800000,48.7],[1372309200000,48.833],[1372395600000,48.86],[1372654800000,49.41],[1372741200000,49.11],[1372827600000,49.177],[1373000400000,49.06],[1373259600000,49.86],[1373346000000,50.1],[1373432400000,51.08],[1373518800000,51.16],[1373605200000,50.92],[1373864400000,51.04],[1373950800000,51.7],[1374037200000,51.06],[1374123600000,51.2],[1374210000000,52.12],[1374469200000,53.15],[1374555600000,54.21],[1374642000000,53.3],[1374728400000,53.58],[1374814800000,52.65],[137507
• [By Nitish]

  Rating: 0.0/5 (0 votes)

  Subscribe via Email Subscribe RSS Comments Please leave your comment:
  More GuruFocus Links Latest Guru Picks Value Strategies Warren Buffett Portfolio Ben Graham Net-Net Real Time Picks Buffett-Munger Screener Aggregated Portfolio Undervalued Predictable ETFs, Options Low P/S Companies Insider Trends 10-Year Financials 52-Week Lows Interactive Charts Model Portfolios DCF Calculator RSS Feed Monthly Newsletters The All-In-One Screener Portfolio Tracking Tool MORE GURUFOCUS LINKS Latest Guru Picks Value Strategies Warren Buffett Portfolio Ben Graham Net-Net Real Time Picks Buffett-Munger Screener Aggregated Portfolio Undervalued Predictable ETFs, Options Low P/S Companies Insider Trends 10-Year Financials 52-Week Lows Interactive Charts Model Portfolios DCF Calculator RSS Feed Monthly Newsletters The All-In-One Screener Portfolio Tracking Tool AAPL STOCK PRICE CHART 91.98 (1y: +57%) $(function(){var seriesOptions=[],yAxisOptions=[],name='AAPL',display='';Highcharts.setOptions({global:{useUTC:true}});var d=new Date();$current_day=d.getDay();if($current_day==5||$current_day==0||$current_day==6){day=4;}else{day=7;} seriesOptions[0]={id:name,animation:false,color:'#4572A7',lineWidth:1,name:name.toUpperCase()+' stock price',threshold:null,data:[[1372654800000,58.46],[1372741200000,59.784],[1372827600000,60.114],[1373000400000,59.631],[1373259600000,59.293],[1373346000000,60.336],[1373432400000,60.104],[1373518800000,61.041],[1373605200000,60.93],[1373864400000,61.063],[1373950800000,61.456],[1374037200000,61.473],[1374123600000,61.68],[1374210000000,60.707],[1374469200000,60.901],[1374555600000,59.856],[1374642000000,62.93],[1374728400000,62.643],[1374814800000,62.999],[1375074000000,63.97],[1375160400000,64.76],[1375246800000,64.647],[1375333200000,65.239],[1375419600000,66.077],[1375678800000,67.064],[1375765200000,66.464],[1375851600000,66.426],[13

10 Best High Tech Stocks To Buy Right Now: RetailMeNot Inc (SALE)

RetailMeNot Inc., incorporated on September 17, 2007, operates digital coupon marketplace, connecting consumers with retailers and brands. As of December 31, 2012, the Company had contracts with more than 10,000 paid retailers. The Company owns and operates digital coupon Websites in the United States (RetailMeNot.com) and the United Kingdom (VoucherCodes.co.uk). The Company�� Websites, mobile applications, e-mail newsletters and alerts and social media presence enable consumers to search for, discover and redeem digital coupons from retailers and brands. Its marketplace features digital coupons across multiple product categories, including clothing; electronics; health and beauty; home and office; travel, food and entertainment; personal and business services; and shoes. It aggregates digital coupons from retailers, performance marketing networks, its user community, its employees and outsourced providers.

Products and Services for Consumers

The Company�� product development approach is centered on building products that enable consumers to discover quality digital coupons, virtually anytime and anywhere, and redeem them online or in-store. The Company�� products and services for consumers are available through its Websites and mobile applications. The Company offers its consumers digital coupons from retailers and brands across multiple product categories. Consumers visiting its marketplace search for and discover digital coupons based on retailer name, product, category, digital coupon type, popularity, success rate and other characteristics. Once a consumer discovers a relevant digital coupon, the consumer clicks on that digital coupon and is directed to the Website of the respective retailer, where the consumer is able to purchase products and redeem the digital coupon.

The Company�� mobile applications allow consumers to shop when they want, where they want. Consumers use its mobile applications to discover, store for use later and access the digit! al coupons they want and to redeem them both online and in-store. They can browse top digital coupons, stores and product category listings. Its mobile applications allow users to share digital coupons with others through e-mail, text message or through social media channels. In addition, utilizing location-based technology, the RetailMeNot iPhone application notifies consumers of savings opportunities when they are shopping near one of 575 geo-fenced shopping malls by sending consumers alerts for digital coupons that can be used in these malls. Consumers can redeem these digital coupons by scanning the barcode at the retailer�� register or by having the sales associate enter the promotional code shown on the consumer�� mobile screen into their point-of-sale system.

Using the Company�� geo-location technology, users that opt in receive an alert when they are near a shopping mall. The alert lists digital coupons that can be redeemed at certain stores within that mall. The mobile application also allows consumers to discover and redeem digital coupons online and to find nearby stores where the digital coupon can be utilized. Consumers can subscribe to receive its periodic e-mail newsletter and alerts. Its e-mail newsletter allows consumers to stay informed about featured digital coupons, while its alerts notify consumers when digital coupons from their preferred retailers become available. As of March 31, 2013, it had over nine million subscribers to its free e-mail newsletters and alerts.

Consumers can engage with the Company on social media channels, such as Facebook, Google+, Pinterest and Twitter, to receive promotional messages from retailers and brands. In addition, it engages consumers through social and gamification features in the Community section of RetailMeNot.com, including the ability to earn points, track dollars users have helped others save, view rankings, earn badges and win prizes.

Products and Services for Retailers

The Company ! provides ! retailers and brands with access to new customers through multiple channels online on its Websites and mobile applications, by e-mail newsletters and alerts and its social media presence, and in-store by displaying a digital coupon on a mobile device or presenting a printed coupon. It allows retailers to provide digital coupons across these multiple channels. It provides its paid retailers with a range of paid placement opportunities. Its placement opportunities include placement within the top coupon carousel of its homepage, the side rail of its category pages, its weekly e-mail newsletter, solo retailer newsletter campaigns and on the landing screen of its mobile applications. It charges a fee for these advertising tools on a campaign basis for a given period of time.

The Company competes with dealspl.us, bradsdeals, dealnews, savings.com, Tech Bargains and Coupon Cabin.

Advisors' Opinion:

• [By WWW.DAILYFINANCE.COM]
  Records fell on Wall Street Friday as another solid report on housing lifted the market for the second day in a row. There's a three-day weekend coming up -- something that often prompts investor caution -- but the gains were broad-based even though volume was fairly light. The VIX, which measures volatility, fell to its lowest level this year. The Dow Jones industrial average (^DJI) gained 63 points, the Nasdaq composite (^IXIC) rose 31, and the Standard & Poor's 500 index (^GPSC) added 8, topping the record high set last week. The Dow Transportation average also raced to an all-time high, lifted by airline stocks. United (UAL) soared more than 4 percent; Delta (DAL) gained more than 1 percent and Southwest (LUV) gained 2 percent. Southwest is at an all-time high, up 79 percent from a year ago. New home sales bounced back with a better than expected 6.4 percent increase last month. Lennar (LEN) and D.R. Horton (DHI) both rose 4 percent. Pulte (PHM), Beazer (BZH) and Hovnanian (HOV) also solid posted gains. Earnings continue to drive retail stocks. Gap (GPS) edged higher even though net fell. Foot Locker (FL) gained 1½ percent after topping expectations. GameStop (GME) rose 4 percent. Its net rose, helped by the rollout last year of new Xbox and PlayStation consoles. Zumiez (ZUMZ) rose 5½ percent on an earnings beat. But Aeropostale (ARO) tumbled 24 percent. Its loss widened and sales declined. The retailer continues to struggle with teen fashion trends. Also on the earnings front, TiVo (TIVO) rose 2 percent as it swung to a profit from a year ago loss. It also reported an increase in the number of subscribers. Hewlett-Packard (HPQ) rose 6 percent on news the company plans to eliminate up to 16,000 additional workers in an effort to cut costs. And several stocks extended big moves from yesterday. Best Buy (BBY) rose more than 3 percent for the second straight day after earnings beat expectations. Isis Pharmaceuticals (ISIS) jumped